The Sartorius Group recorded clear, profitable growth in fiscal year 2025. The positive development was driven by significant growth in the larger and higher-margin recurring business with consumables. As expected, the continued industry-wide investment restraint by customers had a dampening effect on the laboratory instruments and bioprocess equipment business, although this area increasingly stabilized over the course of the year.

Group Business Development

All forecast figures are based on constant currencies, as in past years. Management points out that the dynamics and volatilities in the industry have increased significantly in recent years. In addition, uncertainties due to the changed geopolitical situation, such as the emerging decoupling tendencies of various countries as well as the trade policy framework conditions, are playing a greater role. This results in higher uncertainty when forecasting business figures.